Sherri Dawson Hodgdon, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 273 County Rd, New London, NH 03257 Phone: 603-526-5261 Fax: 603-526-5568 |
Mrs. Lisa Marie Templeton, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 273 County Rd, New London, NH 03257 Phone: 603-526-5233 |
Kathleen E Bowers, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 273 County Rd, New London, NH 03257 Phone: 603-526-5281 |
Mr. Glenn L Perreault, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 82 Newport Rd, New London, NH 03257 Phone: 603-526-2233 Fax: 603-526-2235 |
Laura Lee Mcallister, PHARMD Pharmacist - Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist Medicare: Not Enrolled in Medicare Practice Location: 82 Newport Road, New London, NH 03257 Phone: 802-558-2949 |
News Archive
Women and men age 60 years or older who have a low-trauma osteoporotic fracture have an increased risk of death for the following 5 to 10 years, compared to the general population, and those who experience another fracture increase their risk of death further for an additional 5 years, according to a study in the February 4 issue of JAMA.
This spring marked a seismic shift for digestive and liver disease research at the Medical University of South Carolina with the award of more than $16.5 million in National Institutes of Health funding to open two new tightly integrated centers.
Aeolus Pharmaceuticals, Inc. (OTC Bulletin Board: AOLS) announced today the initiation of a second study, in mice, to determine the optimal length of treatment with AEOL 10150 when used as a countermeasure to Acute Radiation Syndrome (ARS) in the lungs. This study, led by Zeljko Vujaskovic, M.D. Ph.D. of Duke University, is designed to build on the recently completed study that demonstrated the efficacy of AEOL 10150 as a treatment for damage to the lungs due to exposure to radiation, and determine the most effective duration of delivery for treatment after exposure.
Artificial intelligence can enhance the performance of radiologists in reading breast cancer screening mammograms, according to a study published in Radiology: Artificial Intelligence.
A new, streamlined approach to genetic engineering drastically reduces the time and effort needed to insert new genes into bacteria, the workhorses of biotechnology, scientists are reporting.
› Verified 6 days ago